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Abstract
Background: The aim of this study was to assess the serum zinc levels in patients with common oral mucosal 
diseases by comparing these to healthy controls.
Material and Methods: A total of 368 patients, which consisted of 156 recurrent aphthous stomatitis (RAS) pa-
tients, 57 oral lichen planus (OLP) patients, 55 burning mouth syndrome (BMS) patients, 54 atrophic glossitis 
(AG) patients, 46 xerostomia patients, and 115 sex-and age-matched healthy control subjects were enrolled in this 
study. Serum zinc levels were measured in all participants. Statistical analysis was performed using a one-way 
ANOVA, t-test, and Chi-square test. 
Results: The mean serum zinc level in the healthy control group was significantly higher than the levels of all 
other groups (p < 0.001). No individual in the healthy control group had a serum zinc level less than the minimum 
normal value. However, up to 24.7% (13/54) of patients with AG presented with zinc deficiency, while 21.2% 
(33/156) of patients with RAS, 16.4% (9/55) of patients with BMS, 15.2% (7/46) of patients with xerostomia, and 
14.0% (8/57) of patients with OLP were zinc deficient. Altogether, the zinc deficiency rate was 19.02% (70/368) in 
the oral mucosal diseases (OMD) group (all patients with OMD). The difference between the OMD and healthy 
control group was significant (p <0.001). Gender differences in serum zinc levels were also present, although not 
statistically significant.
Conclusions: Zinc deficiency may be involved in the pathogenesis of common oral mucosal diseases. Zinc supple-
mentation may be a useful treatment for oral mucosal diseases, but this requires further investigation; the optimal 
serum level of zinc, for the prevention and treatment of oral mucosal diseases, remains to be determined.
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Introduction 
Oral mucosal diseases (OMD) are common disorders 
affecting all segments of the general population that re-
present a series of abnormal alterations in oral mucosal 
surfaces, which include the labial and buccal mucosae, 
the alveolar mucosa, all parts of tongue, the floor of the 
mouth, and the gingival, palatal, and oropharyngeal 
mucosae (1,2). Although the majority of OMDs are be-
nign, some of them are difficult to manage and usually 
interfere with important oral functions, systemic health, 
and quality of life of the patients.
Recurrent aphthous stomatitis (RAS), oral lichen planus 
(OLP), burning mouth syndrome (BMS), atrophic glos-
sitis (AG), and xerostomia are some of the most preva-
lent oral mucosal diseases and they typically require 
multiple visits to specialist outpatient services. Howe-
ver, the etiology and pathogenesis of these disorders is 
still poorly understood and highly debated (2-5).
Zinc, one of the most important trace elements within 
the human body, plays a variety of critical roles in cell 
growth and reproduction, normal immune functions, 
collagen synthesis, and wound healing (6,7). And zinc 
deficiency is related to multiple physiological abnormali-
ties. Therefore, it is plausible that zinc deficiency might 
be directly involved in the pathogenesis of some oral 
mucous diseases (Fig. 1). At the present, the available 
literature concerning serum zinc levels in patients with 
oral mucosal diseases is severely limited. Moreover, 
findings from several of these studies are inconsistent 
(4,8-14) (Table 1), which demonstrates that further re-
search is needed.
The aim of this study was to assess the serum zinc levels 
of patients with some of the most common oral mucosal 
diseases as compared to healthy controls to determine 
if zinc deficiency may play a role in the etiology and 
pathogenesis of oral mucosal disease.
Material and Methods
A total of 368 patients, consisting of 156 RAS patients, 
57 OLP patients, 55 BMS patients, 54 AG patients and 46 
xerostomia patients were enrolled in this study. Sex- and 
age-matched healthy control subjects were also examined 
(115 total controls). All participants were evaluated from 
January 2013 to May 2015 at the Department of Oral 
Medicine, Shanxi Provincial People’s Hospital, China. 
An OMD diagnosis was established according to accep-
ted criterions (1,4,13-20) (Table 2). Other less common 
diseases, such as oral leukoplakia (OLK), discoid lupus 
erythematosus (DLE), oral acute infection, allergic reac-
tions, and seasonal disorders, such as cheilitis, were not 
included in this study. None of the control subjects had 
any oral mucosal lesions or related systemic diseases.
Fig. 1. Zinc deficiency may be involved in the pathogenesis of common oral mucosal diseases through a variety of mechanisms. 
OLP: oral lichen planus. RAS: Recurrent aphthous stomatitis. BMS: burning mouth síndrome. AG: atrophic glositis.
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For all participants, blood samples were taken after 12 
hours of overnight fasting, medical histories were recor-
ded in detail, and a thorough clinical oral examination 
was performed by the same professional dentist. The 
study was approved by the hospital ethics committee and 
informed consent was obtained from each participant.
Serum zinc levels were measured using a Colorimetric 
Method Zinc Assay Kit (BSBE, Beijing, China). The 
accepted normal serum zinc level is 10.7-17.70 μmol/L. 
Zinc deficiency was defined as a serum Zn level below 
this cutoff.
Statistical analysis was performed using SPSS version 
18.0 software (Chicago, Illinois, USA). Serum zinc lev-
els were compared using a t-test to compare between 
each OMD group and the healthy control group, while 
one-way ANOVA was used to compare among different 
groups. In each group, serum zinc levels were compared 
between male and female using a t-test. In addition, the 
sex ratio was compared for all groups by Chi-square 
test. A p-value < 0.05 was accepted as statistically sig-
nificant.
Results
- The serum zinc levels 
Although the serum zinc levels of some OMD patient 
groups were still in normative range, the mean serum 
zinc level of all patients with any OMD was significantly 
lower than that of the control group (p <0.001, Table 3). 
Country/city Year(ref)
Oral 
mucosal 
diseases
NO.of subjects
(gender composition)
The 
proportion 
of   Zinc 
deficiency
Conclusion
England/London 1982(8) RAS
25 patients (11 males 
and 14 females)
0 Systemic zinc supplementa-
tion is not recommended
Turkey/Erzurun 2003(9) RAS
40 patients ( 14 males, 
26 females)
42.5%
Zinc deficiency is associated 
with RAS.
Systemic zinc supplementa-
tion is recommended
Turkey/Hatay 2014(10) RAS
25 patients (12 males 
and 13 females)
25 healthy controls (13 
males and 12 females)
28% of RAS
4% of controls
Zinc deficiency is a potential 
aetiological factor for RAS
England/London 1991(11) BMS
30 patients (8 males, 22 
females)
30 healthy controls (8 
males, 22 females)
30% of BMS
10% of controls
Zinc deficiency may be 
associated with BMS
Korea/ Seoul 2010(4) BMS 276 patients (not men-tioned in detail) 26.8%
Zinc deficiency might play 
a role in BMS and zinc 
replacement therapy is 
effective
Norway/Oslo 2000(12) AG
311 subjects in the 
hospital group
(140 males, 171 fema-
les)
106 subjects in the 
home group
(54 males, 52 females)
not mentioned
The AG is not related to the 
serum zinc level
Japan / Tokyo 2002(13) Xerostomia
93 patients (27 males, 
66 females)
60 healthy controls
(29 males, 28females)
61.29%
(confirmed or 
suspected )
Zinc deficiency is one cause 
of oral xerostomia
Iran /Tabriz 2014(14) OLP
44 patients and 44 
healthy controls
(35 males and 53 
females in total)
not mentioned
Serum zinc levels were sig-
nificantly reduced in erosive 
OLP compared to non- erosi-
ve OLP.
Table 1. Existing reports of zinc deficiency in oral mucosal diseases in the past three decades.
RAS, recurrent aphthous stomatitis; OLP, Oral lichen planus; BMS, burning mouth syndrome; AG, atrophic glossitis.
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RAS, recurrent aphthous stomatitis; OLP, Oral lichen planus; BMS, burning mouth syndrome; AG, atrophic glossitis; HIV, human immuno-
deficiency virus; HSV, herpes simplex virus; GVHD, Graft-versus-host disease; OLK, oral leukoplakia; PV, pemphigus vulgaris.
Inclusion criteria Exclusion criteria Appendix
RAS  
(1,15,16)
The clinical manifestation is 
characterized by recurrent oral 
ulceration and the history of 
recurrence in at least 1 year.
Behcet’s syndrome, HIV, HSV 
infection, Oral cancer and other 
relevant systemic diseases.
Major and herpetiform RAS 
were not included in this study 
OLP
(14,17,18)
The history, typical oral lesions 
and skin or nail involvement 
are usually sufficient to make a 
clinical diagnosis.
Lichenoid drug reactions, lichenoid 
reactions induced by dental 
restorative material and other 
possible systemic diseases such as 
GVHD
A biopsy is the recommended 
procedure to differentiate it from 
other confusable diseases
BMS
(4,19)
A history of constant burning 
discomfort in the anterior tongue, 
lower lip, or had palate, for more 
than 6 months, with no evidence 
of clinical oral mucosal lesions.
Salivary hypofunction, oral 
candidiasis, medication adverse 
effects, allergic contact stomatitis, 
Diabetes Mellitus and other relevant 
medical history.
AG (20)
Partial or complete loss of filiform 
papillae on the dorsal surface of 
the tongue
Patients with any other relevant 
oral mucosal diseases and systemic 
diseases, such as OLK, OLP,PV, 
pemphigoid, oral candidiasis, 
Sjogren’s syndrome, Diabetes 
Mellitus and diseases of the liver, 
kidney 
Xerostomia 
(13)
Patients who complained of dry 
mouth and with reduced salivary 
flow rates
Patients with conditions affecting the 
salivary gland (Sjogren’s syndrome 
or radiation to the salivary gland), 
relevant medication history and 
Diabetes Mellitus and other relevant 
systemic diseases 
                                                        
Table 2. Diagnostic criteria for the oral mucosal diseases involved in the present study.
Table 3. The basic parameters, zinc levels, and zinc deficiency in each group.
Group
No. of 
subjects
Age
(Mean±SD)
Gender distribution 
(male/female )
Zinc level
(Mean±SD, 
μmol/L)
The proportion of 
zinc deficiency
RAS 156 51.57±16.39 60(38.5%)/96(61.5%) 12.90±2.55 21.2% (33)
OLP 57 52.47±15.13 13(22.8%)/44 (77.2%) 14.37±3.64 14.0% (8)
BMS 55 51.60±11.21 16(29.1%)/39(70.9%) 14.08±3.06 16.4% (9)
Xerostomia 46 55.30±11.98  16(34.8%)/30 (65.2%) 13.33±3.22 15.2% (7)
AG 54 52.61±11.52 19(35.2%)/35(64.8%) 12.97±3.10 24.07%(13)
OMD 368 52.33±14.32 124(33.7%)/244(66.3%) 13.37±3.02 19.02%(70)
Control 115 53.10±15.59 43(37.4%)/72(62.6%) 16.47±2.10 0 (0)
P-value -- 0.626 0.467 <0.001 <0.001
RAS: Recurrent aphthous stomatitis. BMS: burning mouth síndrome. AG: atrophic glossitis. OMD: Oral mucosal diseases.
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Each individual in OMD group had a lower mean serum 
zinc level than the control group (p <0.001).
- Zinc deficiency condition
It is worth noting that in the healthy control group, none of 
the serum zinc levels fell below the minimum normal val-
ue. However, the zinc deficiency rate was 19.02% (70/368) 
for patients with any OMD (all OMD groups collectively). 
Specifically, 24.07% (13/54) of patients with AG were pre-
sented with zinc deficiency, followed by 21.2% (33/156) 
of patients with RAS, 16.4% (9/55) of patients with BMS, 
15.2% (7/46) of patients with xerostomia, and 14.0% (5/57) 
of patients with OLP. Statistically significant differences 
were present between all OMD groups and the healthy 
control group (p <0.001, Table 3).
- Gender differences
Interestingly, the serum zinc levels in males were higher 
than in females for both the control and OMD groups, 
with the exception of the AG group. However, these dif-
ferences were not statistically significant (Table 4).
Group
Zinc level  
(Mean±SD, μmol/L) t-value P-value
Male Female
RAS 12.96±2.66 12.86±2.49 0.239 0.812
OLP 15.80±3.66 13.94±3.56 1.613 0.123
BMS 14.26±3.57 14.00±2.88 0.287 0.776
Xerostomia 14.05±2.96 12.95±3.34 1.109 0.273
AG 12.47±4.10 13.26±2.45 0.770 0.449
Control 16.87±1.60 16.22±2.33 1.765 0.080
Table 4. Gender differences in zinc levels in each group.
Discussion
Zinc serves as a cofactor of at least 3000 human pro-
teins, and it participants in various molecular mecha-
nisms, which means that zinc deficiency may be more 
widely and significantly involved in the pathogenesis of 
human diseases than generally accepted (6,7,21). Zinc 
deficiency results in multiple abnormalities, which have 
a positive correlation with occurrence of the oral mu-
cosal diseases discussed in this paper (Fig. 1). In this 
study, serum zinc levels in OMD patients were signifi-
cantly lower than or were at the lower end of the normal 
range, which is in stark contrast to healthy patients that 
show no signs of zinc deficiency and have zinc levels 
that are in higher end of the normal zinc range. This 
simple observation suggests that serum zinc levels may-
be influence the pathogenesis of oral mucosal diseases.
It is widely believed that atrophic glossitis (AG) may 
be a marker of nutritional deficiency and the significant 
association of deficiency of iron, vitamin B12 and he-
moglobin positivity with AG has been proved (20). In 
the present study, zinc deficiency was found in nearly a 
quarter of the AG patients, compared with no deficiency 
in healthy control. A previous research in Norway re-
vealed that AG was a marker for malnutrition but not 
related to zinc level (12). However, a more recent and 
larger scale study in the same Northern Europe country 
exhibited a relatively high prevalence of zinc deficiency 
in elderly people and demonstrated the significant asso-
ciation between zinc deficiency and the risk of malnutri-
tion (22). The inconsistent results may be due to the lack 
of statistical analysis about the prevalence of zinc defi-
ciency of the AG patients in the former study. Similar to 
our results, the significantly lower serum zinc level or 
higher prevalence of zinc deficiency was also detected 
in patients with RAS (9,10), OLP (14), BMS (4,11) and 
xerostomia (13). Further investigation is required to 
determine if low zinc levels are secondary to or facili-
tate disease development. However, we would suspect 
that low levels of serum zinc are a predisposing factor 
that may render the individual more susceptible to oral 
mucosal dysfunction, precipitating the occurrence of 
OMDs.
The observation that people without OMDs have higher/
normal zinc levels, suggests that zinc homeostasis may 
play a role in OMD prevention and that exogenous zinc 
could be potentially used as a treatment or preventative 
measure for OMDs. Despite our findings that zinc de-
ficiency is common in patients with OMD, additional 
research is needed to determine if modulation of zinc 
levels would be therapeutically advantageous. We spe-
culate that zinc supplementation could be beneficial for 
the treatment of oral mucosal diseases. However, this 
viewpoint is controversial, as many patients exhibit 
a poor response to exogenous zinc and there may be 
a high incidence of undesirable side effects with sys-
temic zinc administration. For example, Wray et al. (8) 
suggested that a routine of zinc supplementation is not 
RAS: Recurrent aphthous stomatitis. BMS: burning mouth síndrome. AG: atro-
phic glositis.
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advisable/beneficial for patients with RAS. But a more 
recent article suggested that zinc supplementation may 
have some positive effects (9). A study in Korea showed 
that zinc supplementation can be effective against BMS 
(4), but this view was challenged in a later publication 
(5). At present, the debate as to the value of zinc sup-
plementation in patients with OMDs continues. Zinc 
supplementation must be carefully considered, since 
the optimal level of zinc in the human body is still un-
known, and the potential toxic effects of zinc must be 
considered (21). 
We demonstrated that the serum zinc level is likely 
lower in women than in men. Similar results have been 
obtained in a large-scale study performed across three 
European countries (23). Coincidentally, the OMD di-
seases discussed here are more prevalent in women than 
man. For example, several studies have denoted that 
BMS is highly associated with the female gender (24, 
25). In addition, OLP is twice as common in women 
as in men (26). Thus, we speculate that the lower level 
of serum zinc may be one factor that helps explain the 
increased prevalence of OMD in women.
Our study reveals significant differences in zinc levels 
between patients with OMD and healthy individuals. 
Therefore, we postulate that zinc deficiency and lower 
serum zinc levels are involved in the pathogenesis of 
oral mucosal diseases and specifically that a decline in 
a person’s serum zinc level may be predisposing factor 
for the development of an OMD. However, additional 
study is necessary to determine the efficiency and safe 
dosing for zinc supplementation in humans, especially 
considering the overt controversy surrounding this ap-
proach. With convenient accessibility and easy trace-
ability, serum zinc levels might also serve a predictive 
or diagnostic factor for the occurrence of OMDs. Ad-
ditional research should help to determine the ideal 
administration strategy and demonstrate the potential 
effectiveness of zinc supplementation.
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